Four years' experience with cyclosporine A in pediatric kidney transplantation.
Hoyer
P F
PF
Department of Pediatric Nephrology and Metabolic Disorders, Medical School Hannover, FRG.
Offner
G
G
Oemar
B S
BS
Brodehl
J
J
Ringe
B
B
Pichlmayr
R
R
D002648:Child; D003524:Cyclosporins / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005919:Glomerular Filtration Rate; D006085:Graft Survival; D006130:Growth Disorders / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation; D008297:Male; D008657:Metabolic Clearance Rate; D011239:Prednisolone / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
D003524:Cyclosporins; D014527:Uric Acid; D011239:Prednisolone